House: Concurrence — PASSED
Email me when HB 2048 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 2048. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill bars the state health‑care cost containment agency from adding tougher prior‑authorization or step‑therapy requirements for non‑opioid prescription drugs used to treat moderate to severe pain. It requires that any controls on those drugs be no more restrictive than those applied to opioid pain medicines. The provision will automatically expire on August 31, 2028.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 2048
3 free questions a day, no accountHearings
- Senate RulesSenate Rules · Apr 20, 2026
- Senate Health and Human ServicesSenate Health and Human Services · Mar 18, 2026
History
- DPA
- DPA/SE
- W/D
- Senate Second Reading
- Senate First Reading
- Transmit to Senate
- PASSED
- DP
- House Placed on Consent Calendar
- DP
- House Second Reading
- House First Reading.
The 12 most recent of 13 recorded actions.
Sponsors
- Selina Bliss (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 2048 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 2048 freeOr ask your AI assistant about HB 2048 directly:
Add to Claude, ChatGPT or Cursor